Works matching DE "OXALIPLATIN"

Results: 2264

Determination of the Relationship between Electromyography-Proven Oxaliplatin-Related Peripheral Neuropathy and Serum Uric Acid Level.

Published in:

Oncology Research & Treatment, 2025, v. 48, n. 5, p. 243, doi. 10.1159/000544035

By:

Tanriverdi, Ozgur;
Dilmen, Yavuz Selim;
Arslan, Burak;
Kutlu, Gulnihal;
Alkan, Ali

Publication type:

Article

Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors.

Published in:

Cancers, 2025, v. 17, n. 9, p. 1561, doi. 10.3390/cancers17091561

By:

Maratta, Maria Grazia;
Sparagna, Ileana;
Occhipinti, Denis;
Roca, Luigi;
Sgambato, Margherita;
Raia, Salvatore;
Bianchi, Antonio;
Chiloiro, Sabrina;
Rossi, Ernesto;
Rindi, Guido;
Tortora, Giampaolo;
Schinzari, Giovanni

Publication type:

Article

Quantification of Oxaliplatin Encapsulated into PLGA Microspheres by TGA.

Published in:

Macromolecular Symposia, 2016, v. 368, n. 1, p. 116, doi. 10.1002/masy.201500181

By:

Saez, Vivian;
Cerruti, Renata;
Ramón, Jose A.;
Santos, Edson R.F.;
Silva, Dionisio Z.;
Pinto, José Carlos;
Souza, Fernando Gomes

Publication type:

Article

Platinum(IV)–Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple‐Negative Breast Cancer Models.

Published in:

Chemistry - A European Journal, 2023, v. 29, n. 59, p. 1, doi. 10.1002/chem.202302045

By:

López‐Hernández, Javier E.;
Nayeem, Nazia;
Cerón‐Carrasco, José P.;
Ahad, Afruja;
Hafeez, Aiman;
León, Ignacio E.;
Contel, Maria

Publication type:

Article

A Rationally Designed Bimetallic Platinum (II)‐Ferrocene Antitumor Agent Induces Non‐Apoptotic Cell Death and Exerts in Vivo Efficacy.

Published in:

Chemistry - A European Journal, 2022, v. 28, n. 46, p. 1, doi. 10.1002/chem.202201259

By:

Gadre, Shubhankar;
Manikandan, M.;
Duari, Prakash;
Chhatar, Sushant;
Sharma, Astha;
Khatri, Subhash;
Kode, Jyoti;
Barkume, Madan;
Kasinathan, Nirmal Kumar;
Nagare, Manasi;
Patkar, Meena;
Ingle, Arvind;
Kumar, Mukesh;
Kolthur‐Seetharam, Ullas;
Patra, Malay

Publication type:

Article

Cucurbit[7]uril Containers for Targeted Delivery of Oxaliplatin to Cancer Cells.

Published in:

Angewandte Chemie, 2013, v. 125, n. 46, p. 12255, doi. 10.1002/ange.201305061

By:

Cao, Liping;
Hettiarachchi, Gaya;
Briken, Volker;
Isaacs, Lyle

Publication type:

Article

Black Phosphorus Nanoparticles Potentiate the Anticancer Effect of Oxaliplatin in Ovarian Cancer Cell Line.

Published in:

Advanced Functional Materials, 2017, v. 27, n. 36, p. 1, doi. 10.1002/adfm.201701955

By:

Fojtů, Michaela;
Xinyi Chia;
Sofer, Zdeněk;
Masařík, Michal;
Pumera, Martin

Publication type:

Article

Black Phosphorus Nanoparticles Potentiate the Anticancer Effect of Oxaliplatin in Ovarian Cancer Cell Line.

Published in:

Advanced Functional Materials, 2017, p. n/a, doi. 10.1002/adfm.201701955

By:

Fojtů, Michaela;
Chia, Xinyi;
Sofer, Zdeněk;
Masařík, Michal;
Pumera, Martin

Publication type:

Article

Cancer Therapy: Black Phosphorus Nanoparticles Potentiate the Anticancer Effect of Oxaliplatin in Ovarian Cancer Cell Line (Adv. Funct. Mater. 36/2017).

Published in:

Advanced Functional Materials, 2017, p. n/a, doi. 10.1002/adfm.201770211

By:

Fojtů, Michaela;
Chia, Xinyi;
Sofer, Zdeněk;
Masařík, Michal;
Pumera, Martin

Publication type:

Article

Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p.

Published in:

Biotechnology Letters, 2021, v. 43, n. 2, p. 339, doi. 10.1007/s10529-020-03036-3

By:

Zhong, Yanmei;
Wang, Dan;
Ding, Yanle;
Tian, Guixin;
Jiang, Bing

Publication type:

Article

Platinum-refractory germ cell tumors: an update on current treatment options and developments.

Published in:

World Journal of Urology, 2017, v. 35, n. 8, p. 1167, doi. 10.1007/s00345-016-1898-z

By:

Oing, Christoph;
Alsdorf, Winfried;
von Amsberg, Gunhild;
Oechsle, Karin;
Bokemeyer, Carsten

Publication type:

Article

New Au(III)- and Fe(III)-based complexes of bio-pharmacological interest: DFT and in silico studies.

Published in:

Theoretical Chemistry Accounts: Theory, Computation, & Modeling, 2023, v. 142, n. 1, p. 1, doi. 10.1007/s00214-022-02940-3

By:

Arbia, Yassamina;
Abtouche, Soraya;
Dahmane, Mohamed;
Brahimi, Meziane

Publication type:

Article

Establishment of childhood hepatoblastoma xenografts and evaluation of the anti-tumour effects of anlotinib, oxaliplatin and sorafenib.

Published in:

Pediatric Surgery International, 2022, v. 38, n. 3, p. 465, doi. 10.1007/s00383-021-05043-5

By:

Yang, Dou;
Chen, Feng;
Gong, Dan;
Zeng, Lei;
Xiang, Deng;
He, Yuanqiao;
Chen, Leifeng;
Yan, Jinlong;
Zhang, Shouhua

Publication type:

Article

Interventional management of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy.

Published in:

2007

By:

Proietti, Stefania;
de Baere, Thierry;
Bessoud, Bertrand;
Doenz, Francesco;
Qanadli, Salah Dine;
Schnyder, Pierre;
Denys, Alban

Publication type:

journal article

Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 807, doi. 10.1007/s00280-011-1764-z

By:

Mazard, T.;
Ychou, M.;
Thezenas, S.;
Poujol, S.;
Pinguet, F.;
Thirion, A.;
Bleuse, J.;
Portales, F.;
Samalin, E.;
Assenat, E.

Publication type:

Article

Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 665, doi. 10.1007/s00280-011-1744-3

By:

King, C.;
Ramachandran, S.;
Chaney, S.;
Collins, L.;
Swenberg, J.;
deKrafft, K.;
Lin, W.;
Cicurel, L.;
Barbier, M.

Publication type:

Article

Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 301, doi. 10.1007/s00280-011-1700-2

By:

Afzal, Shoaib;
Jensen, Søren;
Sørensen, Jens;
Henriksen, Trine;
Weimann, Allan;
Poulsen, Henrik

Publication type:

Article

Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 91, doi. 10.1007/s00280-011-1668-y

By:

Kim, Se;
Shin, Sang;
Kim, Sun;
Lee, Se;
Park, Young;
Park, Se;
Lee, Kyung;
Kim, Tae;
Hong, Yong;
Ahn, Joong

Publication type:

Article

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1431, doi. 10.1007/s00280-011-1601-4

By:

Fogelman, David;
Jafari, Mehrdad;
Varadhachary, Gauri;
Xiong, Henry;
Bullock, Susie;
Ozer, Harold;
Lin, E.;
Morris, Jeffrey;
Cunningham, Patti;
Bennett, Bronwyn;
Abbruzzese, James;
Wolff, Robert

Publication type:

Article

A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1199, doi. 10.1007/s00280-011-1606-z

By:

Zhi, Jianguo;
Chen, Eric;
Major, Pierre;
Burns, Ivon;
Robinson, Bridget;
McKendrick, Joe;
Rittweger, Karen;
Abt, Markus;
Goldstein, David

Publication type:

Article

Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1207, doi. 10.1007/s00280-011-1604-1

By:

De Stefano, Alfonso;
Carlomagno, Chiara;
Pepe, Stefano;
Bianco, Roberto;
De Placido, Sabino

Publication type:

Article

Phase II study of FOLFOX4 with 'wait and go' strategy as first-line treatment for metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1215, doi. 10.1007/s00280-011-1605-0

By:

Kochi, Mitsugu;
Ichikawa, Wataru;
Meguro, Eiji;
Shibata, Hiroyuki;
Fukui, Takuji;
Nagase, Michitaka;
Hoshino, Yutaka;
Takeuchi, Masahiro;
Fujii, Masashi;
Nakajima, Toshifusa

Publication type:

Article

Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 935, doi. 10.1007/s00280-011-1558-3

By:

Hwang, I.;
Jang, J.;
Do, J.;
Kang, J.;
Lee, G.;
Oh, S.;
Kwon, H.;
Jun, H.;
Lim, H.;
Lee, S.;
Chi, K.

Publication type:

Article

Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 263, doi. 10.1007/s00280-011-1633-9

By:

Horimatsu, Takahiro;
Miyamoto, Shin'ichi;
Morita, Shuko;
Mashimo, Yoko;
Ezoe, Yasumasa;
Muto, Manabu;
Chiba, Tsutomu

Publication type:

Article

Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1299, doi. 10.1007/s00280-010-1428-4

By:

Kalimutho, Murugan;
Minutolo, Antonella;
Grelli, Sandro;
Formosa, Amanda;
Sancesario, Giulia;
Valentini, Alessandra;
Federici, Giorgio;
Bernardini, Sergio

Publication type:

Article

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1323, doi. 10.1007/s00280-010-1425-7

By:

Hong, Junshik;
Han, Sae-Won;
Ham, Hye;
Kim, Tae-Yong;
Choi, In;
Kim, Byung-Su;
Oh, Do-Youn;
Im, Seock-Ah;
Kang, Gyeong;
Bang, Yung-Jue;
Kim, Tae-You

Publication type:

Article

Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1111, doi. 10.1007/s00280-010-1322-0

By:

Waddell, T.;
Gollins, S.;
Soe, W.;
Valle, J.;
Allen, J.;
Bentley, D.;
Morris, J.;
Lloyd, A.;
Swindell, R.;
Taylor, M.;
Saunders, M.

Publication type:

Article

Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1167, doi. 10.1007/s00280-010-1413-y

By:

Kaminski, Bettina;
Weigert, Andreas;
Brüne, Bernhard;
Schumacher, Marco;
Wenzel, Uwe;
Steinhilber, Dieter;
Stein, Jürgen;
Ulrich, Sandra

Publication type:

Article

Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1179, doi. 10.1007/s00280-010-1466-y

By:

Basso, Michele;
Modoni, Anna;
Spada, Daniele;
Cassano, Alessandra;
Schinzari, Giovanni;
Lo Monaco, Mauro;
Quaranta, Davide;
Tonali, Pietro;
Barone, Carlo

Publication type:

Article

The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?

Published in:

2011

By:

Park, Susanna;
Lin, Cindy;
Krishnan, Arun;
Kiernan, Matthew

Publication type:

Letter

In reply.

Published in:

2011

By:

Basso, Michele;
Modoni, Anna;
Lo Monaco, Mauro;
Barone, Carlo

Publication type:

Letter

Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 963, doi. 10.1007/s00280-010-1476-9

By:

Garg, Madhu;
Ackland, Stephen

Publication type:

Article

Combination effects of platinum drugs and N, N diethylnorspermine on spermidine/spermine N-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 401, doi. 10.1007/s00280-010-1334-9

By:

Tummala, Ramakumar;
Diegelman, Paula;
Hector, Suzanne;
Kramer, Debora;
Clark, Kimberly;
Zagst, Patricia;
Fetterly, Gerald;
Porter, Carl;
Pendyala, Lakshmi

Publication type:

Article

Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 1, p. 147, doi. 10.1007/s00280-010-1301-5

By:

Bao, Han;
Fang, Wei;
Zhang, Xiao;
Shi, Gen;
Huang, Sui;
Yu, Lan;
Chen, Jin;
Mou, Hai;
Deng, Jing;
Shen, Peng;
Xu, Nong

Publication type:

Article

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 1, p. 41, doi. 10.1007/s00280-010-1281-5

By:

Dalla Chiesa, Matteo;
Tomasello, Gianluca;
Buti, Sebastiano;
Rovere, Rodrigo;
Brighenti, Matteo;
Lazzarelli, Silvia;
Donati, Gianvito;
Passalacqua, Rodolfo

Publication type:

Article

Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 4, p. 659, doi. 10.1007/s00280-009-1206-3

By:

Seung Tae Kim;
Jeeyun Lee;
Se Hoon Park;
Joon Oh Park;
Ho Yeong Lim;
Won Ki Kang;
Jin Yong Kim;
Young Ho Kim;
Dong Kyung Chang;
Poong-Lyul Rhee;
Dae Shick Kim;
Haeran Yun;
Yong Beom Cho;
Hee Cheol Kim;
Seong Hyeon Yun;
Woo Yong Lee;
Ho-Kyung Chun;
Young Suk Park

Publication type:

Article

The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 493, doi. 10.1007/s00280-009-1186-3

By:

Jun Liang;
Tao Jiang;
Ru-yong Yao;
Zi-min Liu;
Hong-ying Lv;
Wei-wei Qi

Publication type:

Article

Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 547, doi. 10.1007/s00280-009-1195-2

By:

Nannizzi, Sara;
Veal, Gareth J.;
Giovannetti, Elisa;
Mey, Valentina;
Ricciardi, Simona;
Ottley, Christopher J.;
Del Tacca, Mario;
Danesi, Romano

Publication type:

Article

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 373, doi. 10.1007/s00280-009-1171-x

By:

Sun Jim Sym;
Min-Hee Ryu;
Hye Jin Kang;
Sung Sook Lee;
Heung-Moon Chang;
Jae Lyun Lee;
Tae Won Kim;
Jeong Hwan Yook;
Sung Tae Oh;
Byung Sik Kim;
Yoon-Koo Kang

Publication type:

Article

Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 817, doi. 10.1007/s00280-009-1085-7

By:

Jacobs, Shana;
McCully, Cynthia L.;
Murphy, Robert F.;
Bacher, John;
Balis, Frank M.;
Fox, Elizabeth

Publication type:

Article

Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 4, p. 641, doi. 10.1007/s00280-009-1069-7

By:

Joung-Soon Jang;
Ho Yeong Lim;
In Gyu Hwang;
Hong Suk Song;
NaeChoon Yoo;
SoYoung Yoon;
Yeul Hong Kim;
Eunsik Park;
Jae Ho Byun;
Myung Ah Lee;
Suk Joong Oh;
Kyung Hee Lee;
Bong Seog Kim;
Sang Cheul Oh;
Sam Yong Kim;
Sang Jae Lee

Publication type:

Article

A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 3, p. 509, doi. 10.1007/s00280-009-1057-y

By:

Locke, Frederick;
Clark, Joseph I.;
Gajewski, Thomas F.

Publication type:

Article

Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 3, p. 473, doi. 10.1007/s00280-009-1052-3

By:

Inkeun Park;
Jae-Lyun Lee;
Min-Hee Ryu;
Heung Moon Chang;
Tae-Won Kim;
Sun-Jin Sym;
Sung Sook Lee;
Geundoo Jang;
Changhoon Yoo;
Kyun-Seop Bae;
Yoon-Koo Kang

Publication type:

Article

A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 151, doi. 10.1007/s00280-009-1018-5

By:

Jen-Shi Chen;
Yee Chao;
Tseng-Sheng Yang;
Wen-Chi Chou;
Li-Tzong Chen;
Kuan-Der Lee;
Yang-Chung Lin

Publication type:

Article

A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 121, doi. 10.1007/s00280-009-1013-x

By:

Saridaki, Zacharenia;
Pappas, Periklis;
Souglakos, John;
Nikolaidou, Martha;
Vardakis, Nikolaos;
Kotsakis, Athanasios;
Marselos, Marios;
Georgoulias, Vassilis;
Mavroudis, Dimitris

Publication type:

Article

Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 5, p. 1001, doi. 10.1007/s00280-009-0956-2

By:

Zhao-Hui Huang;
Dong Hua;
Xiang Du

Publication type:

Article

Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 5, p. 893, doi. 10.1007/s00280-009-0938-4

By:

Comella, Pasquale;
Lorusso, Vito;
Maiorino, Luigi;
Casaretti, Rossana;
Cannone, Michele;
Massidda, Bruno;
Putzu, Carlo;
Leo, Silvana;
Roselli, Mario;
Mancarella, Sergio;
Palmeri, Sergio;
Greco, Ettore;
Vessia, Giacomo;
Sandomenico, Claudia;
Franco, Luca

Publication type:

Article

Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 5, p. 877, doi. 10.1007/s00280-009-0936-6

By:

Dae Young Zang;
Dae Hyun Yang;
Min-Jeong Kim;
Kyung Mi Jang;
Se Won Hwang;
Kyo-Sang Yoo;
Taeho Han;
Ho Young Kim;
Hyo Jung Kim;
Jung Hye Kwon;
Hun Ho Song;
Sarah Park;
Joo Young Jung;
Hyeong Su Kim;
Jung Han Kim

Publication type:

Article

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 317, doi. 10.1007/s00280-008-0873-9

By:

Lee, Kyung Hee;
Kim, Min Kyoung;
Kim, Yeol Hong;
Ryoo, Baek Yeol;
Lim, Ho Yeong;
Song, Hong Suk;
Kim, Hoon Kyo;
Lee, Myung Ah;
Im, Seock Ah;
Chang, Heung Moon;
Cho, Jae Yong;
Zang, Dae Young;
Kim, Bong Seog;
Kim, Jun Suk

Publication type:

Article

A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 371, doi. 10.1007/s00280-008-0883-7

By:

Kim, Hyun Jung;
Lee, Nam Su;
Lee, Sang-Cheol;
Bae, Sang Byung;
Kim, Chan Kyu;
Cheon, Young Gook;
Kim, Young Seok;
Moon, Jong Ho;
Cho, Young Deok;
Park, Sang Heum;
Lee, Kyu Taek;
Park, Sung Kyu;
Won, Jong-Ho;
Park, Hee Sook;
Hong, Dae Sik

Publication type:

Article